Skip to Main Content

Author Details

Catharine M L West
University of Manchester
1981
336
65
PMIDPaper TitleJournal TitlePublished Year
37870417Developing and Validating a Multivariable Prognostic-Predictive Classifier for Treatment Escalation of Oropharyngeal Squamous Cell Carcinoma: The PREDICTR-OPC Study.Clin Cancer Res2024
37908014Reply to: Comments on "(Pre)treatment risk factors for late fatigue and fatigue trajectories following radiotherapy for breast cancer".Int J Cancer2024
36442608Comparing symptom reporting by prostate cancer patients and healthcare professionals in the international multicentre REQUITE study.Radiother Oncol2023
37862240Large-scale meta-genome-wide association study reveals common genetic factors linked to radiation-induced acute toxicities across cancer types.JNCI Cancer Spectr2023
37713940Contouring variation affects estimates of normal tissue complication probability for breast fibrosis after radiotherapy.Breast2023
37548182Comparison of prone and supine positioning for breast cancer radiotherapy using REQUITE data: dosimetry, acute and two years physician and patient-reported outcomes.Acta Oncol2023
37945903Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants.Nat Genet2023
37292833Evaluating Approaches for Constructing Polygenic Risk Scores for Prostate Cancer in Men of African and European Ancestry.medRxiv2023
37085598Technical development and validation of a clinically applicable microenvironment classifier as a biomarker of tumour hypoxia for soft tissue sarcoma.Br J Cancer2023
37311464Evaluating approaches for constructing polygenic risk scores for prostate cancer in men of African and European ancestry.Am J Hum Genet2023
37240301Hypoxia Is Associated with Increased Immune Infiltrates and Both Anti-Tumour and Immune Suppressive Signalling in Muscle-Invasive Bladder Cancer.Int J Mol Sci2023
37437607Genome-wide association study of treatment-related toxicity two years following radiotherapy for breast cancer.Radiother Oncol2023
37403702(Pre)treatment risk factors for late fatigue and fatigue trajectories following radiotherapy for breast cancer.Int J Cancer2023
37331785Normal Tissue Toxicity Prediction: Clinical Translation on the Horizon.Semin Radiat Oncol2023
37198374Prediction of prostate tumour hypoxia using pre-treatment MRI-derived radiomics: preliminary findings.Radiol Med2023
36477705Predicting tumour radiosensitivity to deliver precision radiotherapy.Nat Rev Clin Oncol2023
35079065Development and validation of a hypoxia-associated signature for lung adenocarcinoma.Sci Rep2022
35840111No Association Between Polygenic Risk Scores for Cancer and Development of Radiation Therapy Toxicity.Int J Radiat Oncol Biol Phys2022
35647396Development and Optimization of a Machine-Learning Prediction Model for Acute Desquamation After Breast Radiation Therapy in the Multicenter REQUITE Cohort.Adv Radiat Oncol2022
35730624Comparison of multiple gene expression platforms for measuring a bladder cancer hypoxia signature.Mol Med Rep2022
35431121Effect of Race and Ethnicity on Risk of Radiotherapy Toxicity and Implications for Radiogenomics.Clin Oncol (R Coll Radiol)2022
35595173Similar long-term swallowing outcomes for accelerated, mildly-hypofractionated radiotherapy compared to conventional fractionation in oropharyngeal cancer: A multi-centre study.Radiother Oncol2022
35385334Pretreatment Lymphocyte Count Predicts Benefit From Concurrent Chemotherapy With Radiotherapy in Oropharyngeal Cancer.J Clin Oncol2022
36612036Low CD8 T Cell Counts Predict Benefit from Hypoxia-Modifying Therapy in Muscle-Invasive Bladder Cancer.Cancers (Basel)2022
36452431TORPEdO: A phase III trial of intensity-modulated proton beam therapy versus intensity-modulated radiotherapy for multi-toxicity reduction in oropharyngeal cancer.Clin Transl Radiat Oncol2022
36130474Treatment time and circadian genotype interact to influence radiotherapy side-effects. A prospective European validation study using the REQUITE cohort.EBioMedicine2022
36351720Reirradiation Options for Previously Irradiated Prostate cancer (RO-PIP): Feasibility study investigating toxicity outcomes following reirradiation with stereotactic body radiotherapy (SBRT) versus high-dose-rate brachytherapy (HDR-BT).BMJ Open2022
36195214The correlation between pre-treatment symptoms, acute and late toxicity and patient-reported health-related quality of life in non-small cell lung cancer patients: Results of the REQUITE study.Radiother Oncol2022
36387203High weekly integral dose and larger fraction size increase risk of fatigue and worsening of functional outcomes following radiotherapy for localized prostate cancer.Front Oncol2022
36191651Meta-GWAS identifies the heritability of acute radiation-induced toxicities in head and neck cancer.Radiother Oncol2022
36395551Corrigendum to "Similar long-term swallowing outcomes for accelerated, mildly-hypofractionated radiotherapy compared to conventional fractionation in oropharynx cancer: A multi-centre study" [Radiother. Oncol. 172 (2022) 111-117].Radiother Oncol2022
35152271Prostate cancer risk stratification improvement across multiple ancestries with new polygenic hazard score.Prostate Cancer Prostatic Dis2022
35140340Hypoxia does not predict lack of benefit from adjuvant radiotherapy for patients with early stage breast cancer.Br J Cancer2022
35334417Overview of health-related quality of life and toxicity of non-small cell lung cancer patients receiving curative-intent radiotherapy in a real-life setting (the REQUITE study).Lung Cancer2022
32726420Identifying the Radioresponsive Genome for Genomics-Guided Radiotherapy.J Natl Cancer Inst2021
33548862Improved survival prediction for oropharyngeal cancer beyond TNMv8.Oral Oncol2021
33623038Polygenic hazard score is associated with prostate cancer in multi-ethnic populations.Nat Commun2021
33762140Hypoxia and its Modification in Bladder Cancer: Current and Future Perspectives.Clin Oncol (R Coll Radiol)2021
33846523A miRNA signature predicts benefit from addition of hypoxia-modifying therapy to radiation treatment in invasive bladder cancer.Br J Cancer2021
33539743Hypofractionated radiotherapy in locally advanced bladder cancer: an individual patient data meta-analysis of the BC2001 and BCON trials.Lancet Oncol2021
33756422Lost in application: Measuring hypoxia for radiotherapy optimisation.Eur J Cancer2021
33636229An evaluation of MR based deep learning auto-contouring for planning head and neck radiotherapy.Radiother Oncol2021
33689854Long-Term Outcomes of Radical Radiation Therapy with Hypoxia Modification with Biomarker Discovery for Stratification: 10-Year Update of the BCON (Bladder Carbogen Nicotinamide) Phase 3 Randomized Trial (ISRCTN45938399).Int J Radiat Oncol Biol Phys2021
33929583Immune infiltrate diversity confers a good prognosis in follicular lymphoma.Cancer Immunol Immunother2021
33577642Developing Tumor Radiosensitivity Signatures Using LncRNAs.Radiat Res2021
34819027The effect of hypoxia on PD-L1 expression in bladder cancer.BMC Cancer2021
34593564Impact of hypoxia on cervical cancer outcomes.Int J Gynecol Cancer2021
34247131A data science approach for early-stage prediction of Patient's susceptibility to acute side effects of advanced radiotherapy.Comput Biol Med2021
34210300Repurposing FDA approved drugs as radiosensitizers for treating hypoxic prostate cancer.BMC Urol2021
34256319Dose-escalated intensity-modulated radiotherapy in patients with locally advanced laryngeal and hypopharyngeal cancers: ART DECO, a phase III randomised controlled trial.Eur J Cancer2021
  • 1 - 50 of 336

Recommended Authors

Chen Hu
Johns Hopkins University School of Medicine
Career Start Year 2009
Number of shared co-authors 4
Emmanouil Fokas
Universityhospital Frankfurt
Career Start Year 2007
Number of shared co-authors 5
Ludwig Dubois
Maastricht University
Career Start Year 2004
Number of shared co-authors 11
Zhuo Chen
The First Hospital of Lanzhou University
Career Start Year 2002
Number of shared co-authors 6
Barbara Bachtiary
Center for Proton Therapy, Paul Scherrer Institute
Career Start Year 2000
Number of shared co-authors 1
David Neil Hayes
Center for Cancer Research, University of Tennessee Health Science Center
Career Start Year 1999
Number of shared co-authors 13
Eddy S Yang
University of Alabama at Birmingham, O'Neal Comprehensive Cancer Center
Career Start Year 1999
Number of shared co-authors 4
Phuoc T Tran
University of Maryland School of Medicine
Career Start Year 1996
Number of shared co-authors 19
Johan Bussink
Radboud University, Nijmegen Medical Centre
Career Start Year 1995
Number of shared co-authors 11
Stanley K Liu
Odette Cancer Centre, University of Toronto
Career Start Year 1995
Number of shared co-authors 11
Kevin Camphausen
National Cancer Institute
Career Start Year 1994
Number of shared co-authors 3
Melania Pintilie
Princess Margaret Cancer Centre, University Health Network
Career Start Year 1993
Number of shared co-authors 20
Bradly G Wouters
Princess Margaret Cancer Centre, University Health Network and, University of Toronto
Career Start Year 1993
Number of shared co-authors 16
Theodore L DeWeese
Johns Hopkins University School of Medicine
Career Start Year 1991
Number of shared co-authors 13
Michael Milosevic
Princess Margaret Cancer Centre, University Health Network
Career Start Year 1990
Number of shared co-authors 16
Heidi Lyng
Radiumhospitalet, Oslo University Hosptial
Career Start Year 1990
Number of shared co-authors 4
Anthony Fyles
Princess Margaret Cancer Centre, University Health Network
Career Start Year 1989
Number of shared co-authors 4
Fei-Fei Liu
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Career Start Year 1988
Number of shared co-authors 10
Lisa Licitra
Fondazione IRCCS Istituto Nazionale dei Tumori and University of Milan
Career Start Year 1987
Number of shared co-authors 7
Silvia C Formenti
Weill Cornell Medical College
Career Start Year 1986
Number of shared co-authors 4
Kenneth R Hess
The University of Texas MD Anderson Cancer Center
Career Start Year 1986
Number of shared co-authors 5
Michael Henke
Medical Center, University of Freiburg
Career Start Year 1984
Number of shared co-authors 0
Helen J Ross
Mayo Clinic
Career Start Year 1982
Number of shared co-authors 21
Brian O'Sullivan
Princess Margaret Cancer Centre/University Health Network, University of Toronto
Career Start Year 1982
Number of shared co-authors 13
Andrzej Niemierko
Massachusetts General Hospital
Career Start Year 1982
Number of shared co-authors 8
James W Denham
University of Newcastle
Career Start Year 1980
Number of shared co-authors 5
Andr?? Fortin
Laval University, CHU de Quebec
Career Start Year 1980
Number of shared co-authors 2
David W Hedley
Princess Margaret Cancer Centre, University Health Network
Career Start Year 1975
Number of shared co-authors 7
Richard P Hill
Princess Margaret Cancer Centre
Career Start Year 1968
Number of shared co-authors 6
J. Martin Brown
Stanford University School of Medicine
Career Start Year 1968
Number of shared co-authors 4

Collaborators

Barry S Rosenstein
Co-authored papers 42
Ananya Choudhury
University of Manchester and The Christie NHS Foundation Trust
Co-authored papers 39
Alison M Dunning
Co-authored papers 38
Jenny Chang-Claude
German Cancer Research Center (DKFZ)
Co-authored papers 28
Peter Hoskin
Mount Vernon Cancer Centre
Co-authored papers 24
Dirk De Ruysscher
Maastro Clinic
Co-authored papers 22
Adrian L Harris
University of Oxford
Co-authored papers 19
David E Neal
University of Oxford, John Radcliffe Hospital
Co-authored papers 17
Paul D P Pharoah
Center for Cancer Genetic Epidemiology, University of Cambridge
Co-authored papers 17
Janet L Stanford
Fred Hutchinson Cancer Research Center
Co-authored papers 15
Francesca M Buffa
University of Oxford
Co-authored papers 15
Fredrik Wiklund
Co-authored papers 15
Lorelei A Mucci
Co-authored papers 15
Sonja I Berndt
Co-authored papers 15
Ruth C Travis
Co-authored papers 15
Douglas F Easton
University of Cambridge
Co-authored papers 15
Henrik Gr??nberg
Karolinska Institute
Co-authored papers 15
Sue A Ingles
Co-authored papers 15
Johanna Schleutker
Institute of Biomedicine, University of Turku
Co-authored papers 15
Demetrius Albanes
Co-authored papers 15
Børge G Nordestgaard
Co-authored papers 15
Kathryn L Penney
Co-authored papers 15
Zsofia Kote-Jarai
The Institute of Cancer Research
Co-authored papers 15
Cezary Cybulski
International Hereditary Cancer Center, Pomeranian Medical University
Co-authored papers 15
Christopher A Haiman
University of Southern California
Co-authored papers 14
Monique J Roobol
Erasmus MC Cancer Institute, University Medical Center Rotterdam
Co-authored papers 14
Esther M John
Co-authored papers 13
Rosalind A Eeles
The Institute of Cancer Research
Co-authored papers 12
Sune F Nielsen
Co-authored papers 12
Kay-Tee Khaw
Co-authored papers 12
Release 1.2